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ABSTRACT
Background Creating learning health systems, characterised by the use and 
repeated reuse of demographic, process and clinical data to improve the safety, 
quality and efficiency of care, is a key aim in realising the potential benefits and effi-
ciency savings associated with the implementation of health information technology. 
Objectives We sought to investigate stakeholder perspectives on and expe-
riences of the implementation of hospital electronic prescribing and medicines 
administration (HEPMA) systems in Scotland and use these to inform political deci-
sions on approaches to promoting the use and reuse of digitised prescribing and 
medication administration data in order to improve care processes and outcomes.
Methods We identified and recruited key national stakeholders involved in 
implementing and/or using HEPMA data from generic and specialty systems. 
These included representatives from healthcare settings (i.e. doctors, phar-
macists and nurses), managers of existing national databases, policy makers, 
healthcare analytics companies, system suppliers and patient representatives. 
We conducted multi-disciplinary focus group discussions, audio-recorded these, 
transcribed data verbatim and thematically analysed the transcripts with the help 
of NVivo10. In analysing the data, we drew on theoretical and previous empirical 
work on information infrastructures. 
Results We identified the following key themes: 1) micro-factors – usability of 
systems and motivating users to input data; 2) meso-factors – developing tech-
nical and organisational infrastructures to facilitate the aggregation of data; and 
3) macro-factors – facilitating interoperability and data reuse at larger scales to 
ensure that data are effectively generated and used. 
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Conclusions This work is relevant not only to countries in the early stages 
of data strategy development but also to countries aiming to aggregate data at 
national levels. An overall shared vision of a learning health system at individual, 
organisational and national levels can help to catalyse such data-intensive trans-
formational efforts. 
Keywords: big data, data strategy, health information technology 
INTRODUCTION
“We seek the development of a learning health system 
that is designed to generate and apply the best evidence 
for the collaborative healthcare choices of each patient 
and provider; to drive the process of discovery as a natu-
ral outgrowth of patient care; and to ensure innovation, 
quality, safety, and value in health care”. 
Harvey V. Fineberg, President, Institute of Medicine1
Healthcare is becoming progressively more complex, with an 
ever increasing array of treatment options, older and frailer 
patient populations and increasing costs.2,3 Creating learning 
health systems is now widely seen as essential to address 
these challenges through strategically collecting electronic 
data and repeatedly using these to improve clinical and 
organisational processes.4
Hospital electronic prescribing and medicines administration 
(HEPMA) systems, which allow electronic management of pre-
scribing and administration activities as well as analysis of data 
collected,5 have of late received considerable policy interest 
in Scotland and the United Kingdom (UK). This is in the main 
being fuelled by the desire to improve prescribing safety in 
hospitals.6 What is, however, often less well appreciated is that 
proactive reuse of HEPMA-generated data can also bring con-
siderable benefits. Whilst this is to an extent true of all health 
information technology (HIT), the planned implementation 
of HEPMA systems at scale across National Health Service 
(NHS) Scotland and the fact these systems have the potential 
to transcend professional and organisational boundaries pro-
vided us with an important opportunity and lens through which 
to investigate how best to achieve data-informed service deliv-
ery and decision making in the NHS.7–9
Creating learning health systems through effective use and 
reuse of electronic data is extremely challenging. Underlying 
reasons are both technical and social in nature.10,11 Social 
aspects may, amongst others, include ongoing problems with 
system usability and integration with clinical workflows, which 
can contribute to poor quality data being entered, which fails 
to reflect actual clinical problems and/or procedures. Other 
factors may include social structures and relevant associated 
actors such as policy makers, system suppliers, professional 
groups, organisations, legal entities and patient groups. 
These can have important effects through, for instance, 
setting standards and providing guidance, making and 
influencing strategic decisions, and through direct implemen-
tation-related activities. Wider technical issues may include 
a lack of system interoperability and associated inhibited 
meaningful exchange and potential for aggregation of data. 
An integrated overall data strategy may help to mitigate these 
risks, ensuring that social and technical systems are set up 
from the start to realise effective use and reuse of data to 
improve quality and efficiency. 
Many international examples exist of how such large-scale 
data strategies have been developed in an ad hoc manner, 
often rather reactively addressing problems as they emerge 
as opposed to strategically planning for the efficient reuse 
of data from the start.12,13 Particularly, little is known about 
the needs of different stakeholders in relation to effective use 
and reuse of health-related data, although the value of multi-
stakeholder perspectives has been repeatedly advocated in 
informing policy and some valuable insights have been gen-
erated in international settings.14–16 However, these may not 
be applicable to the Scottish context. Consequently, there is a 
danger of misalignment between needs and healthcare strat-
egy. In addition, there is continuing global debate surround-
ing the degree of central guidance needed and warranted to 
support such initiatives.17 NHS Scotland is in a unique posi-
tion in this respect as the country is relatively small (allowing 
a degree of centralised guidance that is simply not feasible in 
larger countries; see Box 1) and some specialty areas have 
already made significant progress in collecting and reusing 
data at scale. 
Box 1 Key characteristics of NHS Scotland 
Publicly funded health system in the UK
Responsible for approximately 5.3 million people, covering 
a geographical area of 78 km²
14 geographical Health Boards
160,000 employees
Annual budget of approximately £12 billion
Given the opportunity offered by the planned national 
implementation of HEPMA systems across NHS Scotland, 
we sought to investigate stakeholder perspectives and expe-
riences surrounding the continued implementation of HEPMA 
systems and how these can inform political strategy sur-
rounding the use and reuse of the digitised data generated 
through HEPMA. HEPMA systems were chosen as a timely 
exemplar to explore issues related to wider health informa-
tion infrastructures and associated strategy to create learning 
health systems.18,19
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METHODS
In order to stimulate discussion and exchange of experi-
ences, we used a focus group design with two facilitators 
moderating the discussions.20 The focus group is a qualita-
tive research technique that allows participants from different 
backgrounds to actively explore and discuss a specific topic. 
It is well suited to areas where interactions between different 
stakeholders can bring new insights. The event took place in 
September 2015 at The University of Edinburgh, UK. 
Consent and institutional review board 
approval
The work received Institutional Ethical Review Board approval 
from The University of Edinburgh, UK, in November 2014. 
Informed written consent was obtained from participants prior 
to the discussions. In order to protect anonymity, we have ano-
nymised names and places mentioned. 
Recruitment of participants
We purposefully recruited a range of senior figures from differ-
ent sectors across Scotland, selected because of their position 
and strategic role in achieving data-intensive healthcare.21 In 
doing so, we sought to identify stakeholders who were involved 
in the wider socio-political deliberations on HEPMA implementa-
tion. This approach to sampling is based on our previous work, 
where we have mapped networks of stakeholders involved in 
implementing and adopting complex HIT in the NHS.22 We 
began by drawing up a list of sectors that we wanted to be pres-
ent. These included system suppliers; NHS early adopter organ-
isations with medical, pharmacy and nursing representatives; 
patient organisations; NHS services associated with HEPMA; 
and policy makers. As our focus included discussion of exem-
plar approaches surrounding ChemoCare®, antibiotic steward-
ship and pain control (see below for rationale), we deliberately 
recruited prospective participants from these areas. This initial 
list included 28 invitees. As our aim was to gain a comprehen-
sive insight into different viewpoints associated with HEPMA, 
this strategy was viewed as most appropriate to explore how 
systems were and could be developed, implemented and 
optimised. 
We were also open to suggestions from participants in 
relation to further recommendations of additional stakehold-
ers and identified another eight individuals based on these.23 
If invitees were unable to attend, they were asked to recom-
mend alternative participants. 
Data collection and handling 
The topic guide was developed jointly by the authors and 
incorporated feedback from prospective participants (Box 2). 
Discussion topics were selected with the intention to explore 
existing international experiences and from advanced areas 
in Scotland itself with the aim to translate different stake-
holder needs into a feasible political strategy. In analysing 
stakeholder needs, we drew on our previous work surround-
ing social and technological contexts in implementation and 
adoption of complex HIT.22
Box 2 Key topics discussed 
PART 1: How can Scotland learn from existing experi-
ences to effectively utilise data to improve prescribing 
safety, quality and efficiency?
Topic I:   Learning lessons from international experiences 
of exploiting HEPMA data 
Topic II:  Learning lessons from ChemoCare® in NHS 
Scotland
PART 2: How can HEPMA draw more effectively on data 
analytics in the future and what are the implications for 
the next iteration of the eHealth strategy? 
Topic III:  Understanding the needs of different stakehold-
ers using the examples of antibiotic stewardship 
and pain control 
Topic IV:  Implications for policy, strategy and capacity 
development
As the focus was on developing strategy, topics 
addressed existing experiences relating to the implemen-
tation/adoption of ChemoCare® in Scotland (which is very 
advanced in terms of drawing on healthcare data collected 
in different settings).24 This first part was facilitated by AT, a 
senior secondary care pharmacist and academic. The sec-
ond part of the workshop explored potential implications for 
policy and was facilitated by a senior figure in the Scottish 
Government. This facilitator was not involved in setting 
up the research or in analysing/interpreting the findings. 
In order to provide focus, we used examples of antibiotic 
stewardship and pain control, areas that are conceptually 
more advanced in terms of data analytics than prescribing. 
The facilitators paid special attention to ensure a range of 
viewpoints were heard and all participants were encour-
aged to contribute.25 The researchers were present during 
the discussions taking field notes summarising the social 
dynamics and impressions during the workshop,26 but they 
did not actively participate. 
Discussions were digitally audio-recorded and participants 
were provided with an information sheet and a consent form. 
Audio recordings were then transcribed verbatim by a profes-
sional transcriber and transcripts were uploaded into NVivo10 
software for analysis.27
Data analysis
Data were initially analysed combining inductive and 
deductive techniques by KC, an experienced qualitative 
researcher. The emerging themes were then discussed and 
refined by the wider research team. Codes were developed 
based on the four topic areas, extracting common threads 
of discussion and paying particular attention to diverging 
views/perspectives and those that were held by the majority 
of participants. Simultaneously, the researchers developed 
emerging themes that were not immediately visible in the 
initial planned structure of discussions.28 These related to 
perspectives that were perceived as important by attend-
ing individuals and therefore presented recurrent episodes 
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during the discussions. Specific analytical considerations 
included comparing differing viewpoints relating to back-
grounds of individuals, areas of overlap and learning from 
experiences. 
In order to interpret the results, we drew on the work sur-
rounding information infrastructures.29 Information infra-
structures consist of distributed HIT systems that cross 
organisational boundaries. Interpretative approaches can 
help to examine evolving social and technological aspects 
over time. HEPMA systems are used by a variety of special-
ties and data are intended to be aggregated across organ-
isations. The framework therefore provided a useful lens for 
considerations surrounding a national data strategy of imple-
menting HEPMA systems.
Throughout data collection and handling, we sought to 
minimise bias. We have ensured credibility by drawing on 
the focus group as a well-established qualitative research 
method promoting frank and interactive exchange of expe-
riences amongst a varied sample of participants from dif-
ferent backgrounds. We also sought to reduce researcher 
bias through respondent checking, reflexive field notes 
and involvement of the extended research team in the 
analysis. Furthermore, we made a conscious effort to be as 
transparent and detailed as possible in our reporting of the 
methods and findings of the work. This resulted in some mod-
ifications, particularly relating to emerging recommendations 
surrounding policy. 
RESULTS
Overall, we invited 36 individuals, of whom 21 attended on 
the day (Box 3). The others declined due to other prior com-
mitments or did not reply to email contact. We summarise 
key emerging themes in Box 4. A range of stakeholder needs 
and resulting implications for policy emerged from this work. 
Throughout, it became apparent that diverse stakeholder 
groups had different priorities. For instance, whilst healthcare 
professionals were mainly concerned with system usability 
and appropriate resourcing, system suppliers and policymak-
ers were primarily interested in exploring issues relating to 
data reuse at scale.
Box 3 Participants
Nine females, 12 males
Six pharmacists
Four system suppliers
Three antimicrobial prescribing group members
Two policy representatives
One analytic company representative
One academic nurse
One patient association member
One oncology consultant
One pain consultant
One prescribing support unit member 
Micro-factors – usability of systems and 
motivating users
Amongst healthcare professionals, it was noted that the 
systems needed to be usable in order to derive maximum 
benefits. Important characteristics here included an ability to 
be flexible enough to fit in with complex user workflows and, 
most importantly, an intuitive user interface that would not 
slow down healthcare professionals’ work. However, there 
were some concerns amongst healthcare professionals that 
HEPMA systems would not deliver in this respect. 
I think we need really good intuitive systems so they’re 
clinician friendly or patient friendly and we have an awful 
lot of systems that are totally unintuitive to somebody 
coming to them cold, whereas if you go and open up 
your Mac just about anybody could go and do it so it’s 
very intuitive around how you get things to automati-
cally happen but you have quite a lot of clunky systems, 
I’m just hoping HEPMA is a nice user friendly system. 
(Participant 14, Senior NHS/Academic Pharmacist)
Motivating users was often conceptualised as convincing them 
that the data they collected were robust and useful for service 
and clinical improvement, even if data input took them slightly 
longer on electronic systems compared to paper. Discussion of 
this clinical relevance was often perceived to be missing at intro-
ductory sessions.
I think whenever a new HEPMA system is introduced 
in the hospital you get a good sort of presentation and 
instruction and workshop and the technicalities of how 
to use it, but there’s never embedded in that someone 
showing this is why these kind of data are clinically 
important and important to the care of your patient… 
(Participant 11, Academic Pharmacist)
Box 4 Summary of key emerging themes
Micro-factors – usability of systems and motivating 
users 
Flexibility to fit in with complex user workflows
Intuitive user interface that does not slow down work
Feeding back performance data
Evidence of effectiveness
Meso-factors – developing infrastructures to facilitate 
the aggregation of data 
Resources to fund technological infrastructures
Developing capacity and capability for change 
management and data analysis
Macro-factors – facilitating interoperability and data 
reuse at larger scales
National repository of data in order to allow collection and 
meaningful centralised analysis 
Interoperability between systems facilitated by open 
technological standards
Developing local and national systems in synergy and 
feeding back data to organisations
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Feedback on clinical performance to improve individual prac-
tice was seen as particularly beneficial to clinicians. Doing 
so was viewed as a means of closing the improvement cycle 
from collecting clinical data, over analysis and reuse, to direct 
patient care at the individual user level. 
Doctors, nurses, I’m a nurse we all want to know how 
well are we doing in the range, I don’t want to be at 
the bottom I’d like to be at the top, I’m somewhere 
in the middle what can I do to improve my practice? 
(Participant 20, System Supplier)
Meso-factors – developing infrastructures to 
facilitate the aggregation of data
Suppliers and healthcare professionals highlighted that suf-
ficient resources needed to be made available to fund appro-
priate technological infrastructures. They were in many cases 
concerned that the investments made at higher managerial 
levels were not sufficient to support HEPMA systems.
[HEPMA] is very infrastructure dependent. That’s my 
major kind of anxiety that there’s enough investment, 
there’s enough investment in the [Scottish Health 
Boards] to support it. (Participant 12, Antimicrobial 
Prescribing Group)
Infrastructures included building a degree of digital maturity 
as a platform on which HEPMA systems could efficiently 
run. Short-term considerations comprised the development 
of common data models, data storage and warehousing, 
security considerations, wireless networks, and appropriate 
hardware. Medium- to longer-term infrastructural consider-
ations related to the acquisition of software and devices able 
to be optimised to facilitate ‘closing the loop’ between pre-
scribing, administration and dispensing of medicines; as well 
as systems facilitating advanced decision support and data 
analytics. The necessary investment associated with these 
infrastructural developments was seen as significant.
…it’s a spend-to-save initiative and the spend has 
to include the equipment within the hospital to make 
HEPMA a worthwhile investment. (Participant 7, 
Oncology Consultant)
Other essential resources included developing capacity and 
capability for change management to implement systems and 
maintain business continuity, as well as data analysts to help 
support analysis of generated data. It was felt that these up-
front resources were often underestimated in Health Boards 
and in overall HEPMA business cases. Experiences from 
ChemoCare® also supported this.
I think one of the big learning for us with ChemoCare® 
was you make an estimate about the resource require-
ments…you’ll need people at the coalface to give you 
that data and that takes time and you need to design 
the reports. (Participant 3, Cancer Care Pharmacist)
Macro-factors – facilitating interoperability 
and data reuse at larger scales
Participants highlighted the importance of creating a local/
national repository of data in order to allow collection and 
meaningful centralised analysis. However, this required 
some degree of interoperability between different sys-
tems, in order to allow data mapping across technologies 
and healthcare settings. Experiences from collecting data 
on Systemic Anticancer Therapy (SACT) in NHS England 
supported this.
… to collect data across Scotland will require some data 
mapping…we’re seeking some of the learning from NHS 
England who developed a SACT dataset some years 
ago and asked Trusts in England to provide this data and 
that was all going to get fed into this sort of big sort of 
single national database… I think they’re finding there’s 
some challenges around that, I think there are three 
different suppliers of software that are used, plus 50% 
of the Trusts are still paper-based so while all organisa-
tions are mandated to collect data, they don’t have a 
complete dataset in England. (Participant 3, Cancer Care 
Pharmacist)
Open technological standards to allow this level of interoper-
ability were seen as necessary and HEPMA was advocated 
as an exemplar system contributing to this wider information 
consolidation both at local and national levels. 
Developing local and national systems in synergy was 
viewed as important to facilitate local ownership of data. 
Participants from healthcare organisations suggested that 
data needed to be useful at an organisational level in order 
to be effectively aggregated and reused at a national level. 
Considering local, regional and national levels of aggregat-
ing data together was therefore seen as vital.
… at a national level that you can put the intelligence 
around that efficiently and effectively to deploy both 
national policy change and intervention as well as allow-
ing people to feel like they own that data locally… abso-
lutely first and foremost it’s about operational capability 
to deliver safe medicines every time, but then you’ve got 
a layering of that local intelligence and then you’ve got 
the national or the regional intelligence… (Participant 14, 
Senior NHS/Academic Pharmacist)
DISCUSSION
The identification of different stakeholder experiences and 
needs is important to catalyse the development of an inte-
grated data strategy to support the effective use and reuse 
of HEPMA data. Adding to the existing international imple-
mentation-related literature, we have identified a number of 
micro-, meso- and macro-factors that are important in facili-
tating this in the Scottish context. In particular, our work has 
highlighted that appropriate user interfaces and sufficient 
resources are needed to implement systems, and that appro-
priate infrastructures need to be in place to support collecting 
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data for reuse. Such infrastructural considerations are, how-
ever, often neglected in international discourses surround-
ing data strategies, particularly those surrounding capacity 
development.14–16 Our work further indicates that throughout 
data strategy planning, it is important to aim for the creation 
of a learning health system at individual healthcare worker 
and organisational levels, as this can facilitate data collec-
tion and analysis.30 In doing so, there is a need to ensure 
that users and organisations are motivated and supported 
to collect accurate data, e.g. in order to improve clinical and 
organisational performance. Although motivating clinical 
users has been the subject of many implementation-related 
efforts, devising effective ways to feedback clinically relevant 
data to individual users is still a subject of much debate.31 
Examining motivations of organisations in reporting data for 
national aggregation beyond financial incentives is an other 
issue that has received very little attention and would present 
a useful next step in exploring how to promote the adoption 
of national data strategies. 
This work may be seen as a starting point, as it has begun 
investigating how policy decisions in relation to developing 
strategy to create learning health systems in NHS Scotland 
may be conceptualised. As such, we have provided con-
temporaneous insights into senior stakeholder viewpoints 
associated with the key components of a national strategy, 
illustrated the main concerns from a variety of perspectives, 
and provided implications of this work for policy development 
and future evaluation activities.32 These findings now need 
to be incorporated into ongoing UK-wide initiatives such as 
the Farr Institute of Health Informatics Research,33 which is 
aiming to promote research through data linkage. However, 
although we facilitated interactive discussions involving a 
broad range of stakeholders, this work was necessarily lim-
ited in scope as only a small number of senior stakeholders 
were participating (otherwise, the interactive nature of dis-
cussions would have been compromised). The transferabil-
ity of this work to other UK and international contexts may 
therefore need to be assessed by feeding back emerging 
results to a wider range of stakeholders and refining policy 
accordingly. In addition, the close involvement of policy mak-
ers may have influenced the results.
A number of recommendations for national strategies to 
facilitate the creation of learning health systems through 
HEPMA systems emerge from this work, which we have 
summarised in Box 5. Although these are likely to be more 
relevant to countries beginning the journey of system pro-
curement (such as Scotland), they may also be applicable 
to countries considering a more centralised data strategy in 
order to effectively aggregate data from locally implemented 
systems.
Establishing robust information infrastructures is a key for 
any national healthcare strategy. With the aim of aggregating 
data on larger and larger scales, such infrastructures may 
be comparable to other large information networks carrying 
electronic information like the internet and multi-national cor-
porate systems.29,34 There is therefore a wealth of experience 
Box 5 Policy recommendations for national strategies to facilitate the development of learning health systems
Leadership and vision: 
An overall aim to achieve a learning health system should underlie efforts as this can help to ensure that data are used 
with maximum effect to improve individual, organisational and national processes. Learning health systems are not only 
required at organisational levels but also at national levels, ensuring that nationally collected data are effectively fed back 
into organisational activities.
Resources, infrastructure and technical capabilities: 
Robust information infrastructures need to be developed to establish a solid base for data entry, data security and reuse. 
This requires allocation of sufficient resources to procure usable and interoperable systems.
Agreed priorities and definition of minimum datasets:
Standardisation to support semantic/business interoperability is crucial. Minimum datasets at organisational and national 
levels should be defined as an essential component of any data strategy, as this can help to ensure that data are 
strategically collected to be useful and fit for intended purposes. If a minimum dataset is not in place, then collected data 
is less likely to be immediately useful. In addition, it is important to agree some national demonstrator areas/questions 
drawing on collected data.
Stakeholder buy-in and incentives:
Incentives for individuals and organisations need to be put in place to record desired data. This can help to ensure that 
data accurately reflect clinical processes and outcomes.
Monitoring and evaluation from the outset:
There is a need to allocate resources to conduct formative and summative independent academic evaluation of system 
implementation and optimisation activities. This can facilitate learning from experience and help to ensure that technologies 
enable the creation of learning health systems.
Dissemination and building on successes:
Dissemination of lessons learnt can help to avoid negative experiences. This should be characterised by efforts to build on 
successes through disseminating working models of data sharing and analysis.
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with similar technologies from the information systems litera-
ture that healthcare strategy can draw on, particularly in rela-
tion to developing risk mitigation strategies. For instance, it is 
important to recognise that such systems are evolving over 
time and that they have both technological and social ele-
ments.29 In our work, these related to technological systems 
(hardware and software to collect data) as well as users and 
organisations (the social element that involves collection and 
analysis of data). As a result, any strategy to implement asso-
ciated technologies and social processes needs to be flexible 
enough to cope with the evolving nature of such systems and 
their evolving use over time.34 Similarly, technologies need to 
be adaptable enough to allow for changes in strategy (e.g. in 
data to be collected) and social contexts of use (e.g. chang-
ing professional structures). A number of implications for 
the design of systems drawing on the literature surrounding 
information infrastructures have already been outlined and 
may be applicable to healthcare. These include the need to 
ensure usability, if possible draw on existing infrastructures, 
expand use of systems with persuasive tactics, make techno-
logical systems easy to use to promote usability and modula-
rise the system in order to promote flexibility.29
International experiences may also facilitate the refine-
ment of a national (Scotland- or UK-wide) healthcare strat-
egy. For instance, ongoing work surrounding digital maturity 
in England could help other countries to benchmark and serve 
as a starting point to develop relevant guidance.35 Similarly, 
experiences from large health systems in North American set-
tings may help to develop governance structures (such as, for 
example, surrounding data stewardship and potential partner-
ships with industry), and promote learning from experiences 
(e.g. surrounding dealing with potential confounders and time-
liness of data, or in helping to establish specialist roles that 
emerge from new systems such as HEPMA Pharmacists).36 
Drawing on experiences from other industries, such as bank-
ing and retail, may also be fruitful in terms of future work. There 
will further be a need to ensure continued national high-level 
leadership and drive through, for instance, the appointment 
of Chief Data Scientists,37 and the continued use of financial 
incentives to promote collection of electronic health data.38
CONCLUSIONS
Achieving the vision of learning health systems can be greatly 
facilitated by drawing on existing national and international 
experiences. The example of developing HEPMA strategy 
within NHS Scotland has allowed us to identify key consid-
erations that should be taken into account when planning 
for national strategies to aggregate healthcare data. These 
include defining minimum datasets, creating incentives, and 
promoting a learning health system through data feedback 
loops at different levels. At present, a truly learning health 
system is still a vision in most countries, but this work may 
be used as a starting point to promote international efforts to 
aggregate data at national scales. 
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